US Bancorp’s BioCardia BCDA Stock Holding History

US Bancorp’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-241	Closed	-$11K	–	4097
2021 Q3	$11K	Buy	+241	New	+$11.8K	﹤0.01%	3390

Other funds holding BCDA

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Family Management New York $975M AUM 23.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

US Bancorp's BCDA Position: Q4 2021 in Review

US Bancorp sold out of BioCardia (BCDA) in Q4 2021, closing a stake of 241 shares — an estimated $11K sold.

US Bancorp first reported a position in BCDA in Q3 2021 and held it in 1 quarter. The position peaked at $11K in Q3 2021. 23 funds tracked by Wall St. Rank hold BCDA as of Q4 2021.

US Bancorp reported no remaining BioCardia position as of Q4 2021 after selling out during the quarter.
US Bancorp sold 241 BioCardia shares in Q4 2021, an estimated $11K.
US Bancorp first reported a position in BioCardia in Q3 2021 and held it in 1 quarter.
US Bancorp's BioCardia position peaked at $11K in Q3 2021.
23 funds tracked by Wall St. Rank held BioCardia as of Q4 2021.

Based on US Bancorp's 13F filing for Q4 2021, filed 11 Feb 2022.